Pharmacological and biological therapeutic strategies for osteogenesis imperfecta
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological and biological therapeutic strategies for osteogenesis imperfecta
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
Volume 172, Issue 4, Pages 367-383
Publisher
Wiley
Online
2016-11-04
DOI
10.1002/ajmg.c.31532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Bisphosphonates on Bone Mineral Density and Fracture Rate in Patients With Osteogenesis Imperfecta
- (2016) Chang Gui Shi et al. AMERICAN JOURNAL OF THERAPEUTICS
- Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy
- (2016) Kakoli Mukherjee et al. BIOCHEMICAL PHARMACOLOGY
- Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate
- (2016) K. Lindahl et al. BONE
- Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations — genotype–phenotype correlations and effect of bisphosphonate treatment
- (2016) Atsuko Sato et al. BONE
- Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation
- (2016) Denise M. van de Laarschot et al. BONE
- Effect of high-dose vitamin D supplementation on bone density in youth with osteogenesis imperfecta: A randomized controlled trial
- (2016) Laura Plante et al. BONE
- Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development
- (2016) Ana Prates Soares et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Effects of Daily or Cyclic Teriparatide on Bone Formation in the Iliac Crest in Women on No Prior Therapy and in Women on Alendronate
- (2016) David W Dempster et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Treatment Improves the Bone Phenotype ofCrtap-/-Mice, a Model of Recessive Osteogenesis Imperfecta
- (2016) Ingo Grafe et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone Material Properties in Osteogenesis Imperfecta
- (2016) Nick Bishop JOURNAL OF BONE AND MINERAL RESEARCH
- Osteogenesis imperfecta
- (2016) Antonella Forlino et al. LANCET
- Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice
- (2016) Abbhirami Rajagopal et al. MOLECULAR GENETICS AND METABOLISM
- Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study
- (2016) R. Rizzoli et al. OSTEOPOROSIS INTERNATIONAL
- Teriparatide for osteoporosis: importance of the full course
- (2016) R. Lindsay et al. OSTEOPOROSIS INTERNATIONAL
- New anti-resorptives and antibody mediated anti-resorptive therapy
- (2016) A. J. Farrier et al. Bone & Joint Journal
- Advances in the Classification and Treatment of Osteogenesis Imperfecta
- (2016) Inas H. Thomas et al. Current Osteoporosis Reports
- Recessive Osteogenesis Imperfecta Caused by Missense Mutations in SPARC
- (2015) Roberto Mendoza-Londono et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Cole-Carpenter Syndrome Is Caused by a Heterozygous Missense Mutation in P4HB
- (2015) Frank Rauch et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mutations in SEC24D, Encoding a Component of the COPII Machinery, Cause a Syndromic Form of Osteogenesis Imperfecta
- (2015) Lutz Garbes et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Multidisciplinary Treatment of Severe Osteogenesis Imperfecta: Functional Outcomes at Skeletal Maturity
- (2015) Kathleen Montpetit et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- The developmental basis of mesenchymal stem/stromal cells (MSCs)
- (2015) Guojun Sheng BMC DEVELOPMENTAL BIOLOGY
- Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment
- (2015) Benjamin P. Sinder et al. BONE
- Cathepsin K Inhibition: A New Mechanism for the Treatment of Osteoporosis
- (2015) Le T. Duong et al. CALCIFIED TISSUE INTERNATIONAL
- Mutations inSEC24Dcause autosomal recessive osteogenesis imperfecta
- (2015) S. Moosa et al. CLINICAL GENETICS
- Identification andIn VivoFunctional Characterization of Novel Compound HeterozygousBMP1Variants in Osteogenesis Imperfecta
- (2015) Sung Yoon Cho et al. HUMAN MUTATION
- IFITM5 mutations and osteogenesis imperfecta
- (2015) Nobutaka Hanagata JOURNAL OF BONE AND MINERAL METABOLISM
- A Transgenic Mouse Model of OI Type V Supports a Neomorphic Mechanism of theIFITM5Mutation
- (2015) Caressa D Lietman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Defective Proteolytic Processing of Fibrillar Procollagens and Prodecorin Due to BiallelicBMP1Mutations Results in a Severe, Progressive Form of Osteogenesis Imperfecta
- (2015) Delfien Syx et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonates for the Prevention of Fractures in Osteogenesis Imperfecta: Meta-Analysis of Placebo-Controlled Trials
- (2015) Jannie D Hald et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab
- (2015) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years
- (2015) Telma Palomo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
- (2015) Robert R. Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience
- (2015) Sobenna George et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation
- (2015) C. M. Weaver et al. OSTEOPOROSIS INTERNATIONAL
- Stem cell transplantation before birth - a realistic option for treatment of osteogenesis imperfecta?
- (2015) Magnus Westgren et al. PRENATAL DIAGNOSIS
- Sclerostin and skeletal health
- (2015) Maryam Sharifi et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Identification of the Common Origins of Osteoclasts, Macrophages, and Dendritic Cells in Human Hematopoiesis
- (2015) Yanling Xiao et al. Stem Cell Reports
- Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment
- (2014) F.S. Van Dijk et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta
- (2014) Andreas Roschger et al. BONE
- Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible
- (2014) Y. Zhuo et al. BONE
- Osteogenesis imperfecta due to mutations in non-collagenous genes
- (2014) Joan C. Marini et al. CURRENT OPINION IN PEDIATRICS
- Connective tissue alterations in Fkbp10−/− mice
- (2014) Caressa D. Lietman et al. HUMAN MOLECULAR GENETICS
- The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations
- (2014) Kyu Sang Joeng et al. HUMAN MOLECULAR GENETICS
- The incidence of and risk factors for developing atypical femoral fractures in Japan
- (2014) Yoshitomo Saita et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Topological Mapping of BRIL Reveals a Type II Orientation and Effects of Osteogenesis Imperfecta Mutations on Its Cellular Destination
- (2014) Alexa Patoine et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of Cathepsin K Increases Modeling-Based Bone Formation, and Improves Cortical Dimension and Strength in Adult Ovariectomized Monkeys
- (2014) Brenda L Pennypacker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoporosis Caused by Mutations inPLS3: Clinical and Bone Tissue Characteristics
- (2014) Somayyeh Fahiminiya et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Evaluation of teriparatide treatment in adults with osteogenesis imperfecta
- (2014) Eric S. Orwoll et al. JOURNAL OF CLINICAL INVESTIGATION
- Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta
- (2014) Ingo Grafe et al. NATURE MEDICINE
- Genotype–Phenotype Correlation — Promiscuity in the Era of Next-Generation Sequencing
- (2014) James T. Lu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Atypical Femoral Fracture during and after Bisphosphonate Use
- (2014) Jörg Schilcher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI
- (2014) Heike Hoyer-Kuhn et al. Orphanet Journal of Rare Diseases
- Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength
- (2014) B. P. Sinder et al. OSTEOPOROSIS INTERNATIONAL
- Update on the Evaluation and Treatment of Osteogenesis Imperfecta
- (2014) Jennifer Harrington et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Mutations in WNT1 Cause Different Forms of Bone Fragility
- (2013) Katharina Keupp et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A recurrent mutation in the 5′-UTR ofIFITM5causes osteogenesis imperfecta type V
- (2013) Masaki Takagi et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I
- (2013) Davide Gatti et al. CALCIFIED TISSUE INTERNATIONAL
- Bone Collagen: New Clues to Its Mineralization Mechanism from Recessive Osteogenesis Imperfecta
- (2013) David R. Eyre et al. CALCIFIED TISSUE INTERNATIONAL
- The Osteocyte: An Endocrine Cell … and More
- (2013) Sarah L. Dallas et al. ENDOCRINE REVIEWS
- Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta
- (2013) Julie Rousseau et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Allele Dependent Silencing of Collagen Type I Using Small Interfering RNAs Targeting 3'UTR Indels - a Novel Therapeutic Approach in Osteogenesis Imperfecta
- (2013) Katarina Lindahl et al. International Journal of Medical Sciences
- Phenotypic Variability of Osteogenesis Imperfecta Type V Caused by anIFITM5Mutation
- (2013) Jay R Shapiro et al. JOURNAL OF BONE AND MINERAL RESEARCH
- WNT signaling in bone homeostasis and disease: from human mutations to treatments
- (2013) Roland Baron et al. NATURE MEDICINE
- PLS3 Mutations in X-Linked Osteoporosis with Fractures
- (2013) Fleur S. van Dijk et al. NEW ENGLAND JOURNAL OF MEDICINE
- WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta
- (2013) Christine M. Laine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans
- (2013) Sofie Symoens et al. Orphanet Journal of Rare Diseases
- Next-generation sequencing for disorders of low and high bone mineral density
- (2013) G. Sule et al. OSTEOPOROSIS INTERNATIONAL
- Sclerostin Inhibition Reverses Skeletal Fragility in an Lrp5-Deficient Mouse Model of OPPG Syndrome
- (2013) R. Kedlaya et al. Science Translational Medicine
- Pre- and Postnatal Transplantation of Fetal Mesenchymal Stem Cells in Osteogenesis Imperfecta: A Two-Center Experience
- (2013) Cecilia Götherström et al. Stem Cells Translational Medicine
- A Single Recurrent Mutation in the 5′-UTR of IFITM5 Causes Osteogenesis Imperfecta Type V
- (2012) Tae-Joon Cho et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Attenuated BMP1 Function Compromises Osteogenesis, Leading to Bone Fragility in Humans and Zebrafish
- (2012) P.V. Asharani et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Mutation in the 5′-UTR of IFITM5 Creates an In-Frame Start Codon and Causes Autosomal-Dominant Osteogenesis Imperfecta Type V with Hyperplastic Callus
- (2012) Oliver Semler et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms
- (2012) S. Otsuru et al. BLOOD
- Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen
- (2012) U. Schwarze et al. HUMAN MOLECULAR GENETICS
- Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome-Osteogenesis imperfecta phenotypic spectrum
- (2012) Maria Trinidad Puig-Hervás et al. HUMAN MUTATION
- Absence ofFKBP10in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix
- (2012) Aileen M. Barnes et al. HUMAN MUTATION
- Safety of osteoanabolic therapy: A decade of experience
- (2012) Cristiana Capriani et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Lack of Circulating Pigment Epithelium-Derived Factor Is a Marker of Osteogenesis Imperfecta Type VI
- (2012) Frank Rauch et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of theIFITM5c.−14C>T mutation in all patients
- (2012) Frank Rauch et al. JOURNAL OF MEDICAL GENETICS
- Study of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined byTMEM38Bmutation
- (2012) Ranad Shaheen et al. JOURNAL OF MEDICAL GENETICS
- Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
- (2012) Kurt A. Kennel et al. MAYO CLINIC PROCEEDINGS
- Exome Sequencing Identifies Truncating Mutations in Human SERPINF1 in Autosomal-Recessive Osteogenesis Imperfecta
- (2011) Jutta Becker et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans
- (2011) Ranad Shaheen et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Endoplasmic reticulum stress or mutation of an EF-hand Ca2+-binding domain directs the FKBP65 rotamase to an ERAD-based proteolysis
- (2011) Lindsey A. Murphy et al. CELL STRESS & CHAPERONES
- EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta
- (2011) Fleur S van Dijk et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Reshaping of Vertebrae during Treatment with Neridronate or Pamidronate in Children with Osteogenesis Imperfecta
- (2011) O. Semler et al. Hormone Research in Paediatrics
- Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes
- (2011) Shawna M. Pyott et al. HUMAN MOLECULAR GENETICS
- Mutations in SERPINF1 cause osteogenesis imperfecta type VI
- (2011) Erica P Homan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Lack of expression ofSERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen
- (2011) Giacomo Venturi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Predictors and Correlates of Vitamin D Status in Children and Adolescents with Osteogenesis Imperfecta
- (2011) Thomas Edouard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- New perspectives on osteogenesis imperfecta
- (2011) Antonella Forlino et al. Nature Reviews Endocrinology
- Do patients with osteogenesis imperfecta need individualized nutritional support?
- (2011) Carlos Eduardo Andrade Chagas et al. NUTRITION
- Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta
- (2011) R. Bargman et al. OSTEOPOROSIS INTERNATIONAL
- Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
- (2011) Asiri R. Wijenayaka et al. PLoS One
- Identification of a Frameshift Mutation in Osterix in a Patient with Recessive Osteogenesis Imperfecta
- (2010) Pablo Lapunzina et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal-Recessive Osteogenesis Imperfecta
- (2010) Yasemin Alanay et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Homozygosity for a Missense Mutation in SERPINH1, which Encodes the Collagen Chaperone Protein HSP47, Results in Severe Recessive Osteogenesis Imperfecta
- (2010) Helena E. Christiansen et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Dynamics of the transition from osteoblast to osteocyte
- (2010) Sarah L. Dallas et al. Annals of the New York Academy of Sciences
- Birth prevalence rates of skeletal dysplasias
- (2010) Claude Stoll et al. CLINICAL GENETICS
- RANKL Inhibition Improves Bone Properties in a Mouse Model of Osteogenesis Imperfecta
- (2010) Renee Bargman et al. CONNECTIVE TISSUE RESEARCH
- GH in combination with bisphosphonate treatment in osteogenesis imperfecta
- (2010) Franco Antoniazzi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Genotype–phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I
- (2010) Frank Rauch et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo
- (2010) James R Edwards et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Mutations in FKBP10 cause recessive osteogenesis imperfecta and bruck syndrome
- (2010) Brian P Kelley et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Alendronate for the Treatment of Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study
- (2010) L. M. Ward et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Chaperoning osteogenesis: new protein-folding disease paradigms
- (2010) Elena Makareeva et al. TRENDS IN CELL BIOLOGY
- PPIB Mutations Cause Severe Osteogenesis Imperfecta
- (2009) Fleur S. van Dijk et al. AMERICAN JOURNAL OF HUMAN GENETICS
- PEDF regulates osteoclasts via osteoprotegerin and RANKL
- (2009) Toru Akiyama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Osteogenesis imperfecta: questions and answers
- (2009) Jay R Shapiro et al. CURRENT OPINION IN PEDIATRICS
- Cell therapy for disorders of bone
- (2009) Reena Jethva et al. CYTOTHERAPY
- Biochemical Characterization of the Prolyl 3-Hydroxylase 1·Cartilage-associated Protein·Cyclophilin B Complex
- (2009) Yoshihiro Ishikawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Location of 3-Hydroxyproline Residues in Collagen Types I, II, III, and V/XI Implies a Role in Fibril Supramolecular Assembly
- (2009) Mary Ann Weis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Risedronate in the Treatment of Mild Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study
- (2009) Frank Rauch et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model
- (2009) Ethan Daley et al. JOURNAL OF BONE AND MINERAL RESEARCH
- TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
- (2009) Yi Tang et al. NATURE MEDICINE
- Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
- (2009) Khalid S. Mohammad et al. PLoS One
- CRTAPandLEPRE1mutations in recessive osteogenesis imperfecta
- (2008) Dustin Baldridge et al. HUMAN MUTATION
- The Rough Endoplasmic Reticulum-resident FK506-binding Protein FKBP65 Is a Molecular Chaperone That Interacts with Collagens
- (2008) Yoshihiro Ishikawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation
- (2008) A Willaert et al. JOURNAL OF MEDICAL GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started